256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval
The Readout Loud
00:00
Introduction
The European Union wants to make sweeping changes to how new drugs are regulated on the continent. New York City is investing over a billion dollars in life sciences innovation, workforce development, and infrastructure. The city has sparked a life Sciences boom that gives new entrants access to space, capital, research, and talent.
Transcript
Play full episode
